RBLX
VENTE TOTALE: 52 568 titres (~1 985 892,88 $ US)
- Insiders
- Baszucki David
- Total bought
- —
- Total sold
- $1,985,893
- Last activity
- 2026-08-20
- Last synced
-
2026-08-26 03:23:35
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-27
RBLX presents a deeply unfavorable risk/reward setup: a weak liquidity score (45) signals structural balance sheet fragility with a sub-1.0 current ratio and high leverage, while the catalyst score (10) reflects an…
The first sentence of the analysis written for RBLX on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 78.1% | 77.8% | 76.8% | 75.4% | 74.1% | |
| Ebit Margin | -21.0% | -24.9% | -40.0% | -40.1% | -25.9% | |
| Ebitda Margin | -16.4% | -18.6% | -32.5% | -34.2% | -22.0% | |
| Operating Profit Margin | -25.2% | -29.5% | -45.0% | -41.5% | -25.8% | |
| Pretax Profit Margin | -21.8% | -26.0% | -41.4% | -41.8% | -26.3% | |
| Continuous Operations Profit Margin | -21.9% | -26.1% | -41.4% | -42.0% | -26.2% | |
| Net Profit Margin | -21.8% | -26.0% | -41.2% | -41.5% | -25.6% | |
| Bottom Line Profit Margin | -21.8% | -26.0% | -41.2% | -41.5% | -25.6% | |
| Current Ratio | 0.955 | 1.018 | 1.073 | 1.547 | 1.730 | |
| Quick Ratio | 0.955 | 1.018 | 1.073 | 1.547 | 1.730 | |
| Solvency Ratio | -0.091 | -0.102 | -0.155 | -0.157 | -0.105 | |
| Cash Ratio | 0.235 | 0.194 | 0.222 | 1.200 | 1.386 | |
| Price To Earnings Ratio | -52.617 | -40.181 | -24.449 | -18.361 | -106.351 | |
| Price To Earnings Growth Ratio | -7.577 | 1.747 | -1.184 | -0.307 | -1.000 | |
| Forward Price To Earnings Growth Ratio | -7.577 | 1.747 | -1.184 | -0.307 | -1.000 | |
| Price To Earnings Diluted Ratio | -52.617 | -40.181 | -24.449 | -18.361 | -106.351 | |
| Price To Earnings Diluted Growth Ratio | -7.577 | 1.747 | -1.184 | -0.307 | -1.000 | |
| Price To Book Ratio | 141.652 | 169.176 | 369.431 | 55.386 | 89.232 | |
| Price To Sales Ratio | 11.426 | 10.401 | 10.068 | 7.618 | 27.191 | |
| Price To Free Cash Flow Ratio | 41.304 | 58.418 | 227.265 | -290.397 | 93.524 | |
| Price To Operating Cash Flow Ratio | 31.107 | 45.558 | 61.513 | 45.897 | 79.174 | |
| Debt To Assets Ratio | 0.189 | 0.252 | 0.286 | 0.290 | 0.271 | |
| Debt To Equity Ratio | 4.570 | 8.152 | 23.107 | 5.087 | 2.109 | |
| Debt To Capital Ratio | 0.820 | 0.891 | 0.959 | 0.836 | 0.678 | |
| Long Term Debt To Capital Ratio | 0.716 | 0.820 | 0.929 | 0.764 | 0.628 | |
| Financial Leverage Ratio | 24.227 | 32.401 | 80.850 | 17.565 | 7.798 | |
| Working Capital Turnover Ratio | -59.807 | 25.025 | 3.542 | 1.513 | 2.158 | |
| Operating Cash Flow Ratio | 0.350 | 0.224 | 0.150 | 0.149 | 0.304 | |
| Operating Cash Flow Sales Ratio | 0.367 | 0.228 | 0.164 | 0.166 | 0.343 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.753 | 0.780 | 0.271 | -0.158 | 0.847 | |
| Debt Service Coverage Ratio | -14.723 | -16.374 | -22.389 | -19.182 | -60.171 | |
| Interest Coverage Ratio | -30.785 | -25.819 | -30.930 | -23.151 | -70.748 | |
| Short Term Operating Cash Flow Coverage Ratio | 122.201 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.996 | 0.456 | 0.260 | 0.237 | 0.534 | |
| Capital Expenditure Coverage Ratio | 4.051 | 4.543 | 1.371 | 0.864 | 6.518 | |
| Dividend Paid And Capex Coverage Ratio | 4.051 | 4.543 | 1.371 | 0.864 | 6.518 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -70.404 | -57.526 | -32.129 | -20.383 | -119.635 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 78.1% | ▲0.3% | ▲1.7% |
| Ebit Margin | -21.0% | ▲3.9% | ▲9.4% |
| Ebitda Margin | -16.4% | ▲2.2% | ▲8.3% |
| Operating Profit Margin | -25.2% | ▲4.3% | ▲8.2% |
| Pretax Profit Margin | -21.8% | ▲4.2% | ▲9.6% |
| Continuous Operations Profit Margin | -21.9% | ▲4.2% | ▲9.6% |
| Net Profit Margin | -21.8% | ▲4.2% | ▲9.4% |
| Bottom Line Profit Margin | -21.8% | ▲4.2% | ▲9.4% |
| Current Ratio | 0.956 | ▼-0.062 | ▼-0.309 |
| Quick Ratio | 0.956 | ▼-0.062 | ▼-0.309 |
| Solvency Ratio | -0.091 | ▲0.010 | ▲0.030 |
| Cash Ratio | 0.235 | ▲0.041 | ▼-0.412 |
| Price To Earnings Ratio | -52.617 | ▼-12.436 | ▼-4.225 |
| Price To Earnings Growth Ratio | -7.577 | ▼-9.324 | ▼-5.913 |
| Forward Price To Earnings Growth Ratio | -7.577 | ▼-9.324 | ▼-5.913 |
| Price To Earnings Diluted Ratio | -52.617 | ▼-12.436 | ▼-4.225 |
| Price To Earnings Diluted Growth Ratio | -7.577 | ▼-9.324 | ▼-5.913 |
| Price To Book Ratio | 141.651 | ▼-27.524 | ▼-23.324 |
| Price To Sales Ratio | 11.426 | ▲1.025 | ▼-1.915 |
| Price To Free Cash Flow Ratio | 41.304 | ▼-17.114 | ▲15.281 |
| Price To Operating Cash Flow Ratio | 31.107 | ▼-14.451 | ▼-21.543 |
| Debt To Assets Ratio | 0.189 | ▼-0.063 | ▼-0.069 |
| Debt To Equity Ratio | 4.570 | ▼-3.583 | ▼-4.035 |
| Debt To Capital Ratio | 0.821 | ▼-0.070 | ▼-0.016 |
| Long Term Debt To Capital Ratio | 0.716 | ▼-0.104 | ▼-0.056 |
| Financial Leverage Ratio | 24.227 | ▼-8.174 | ▼-8.341 |
| Working Capital Turnover Ratio | -59.807 | ▼-84.832 | ▼-54.293 |
| Operating Cash Flow Ratio | 0.350 | ▲0.126 | ▲0.115 |
| Operating Cash Flow Sales Ratio | 0.367 | ▲0.139 | ▲0.114 |
| Free Cash Flow Operating Cash Flow Ratio | 0.753 | ▼-0.027 | ▲0.255 |
| Debt Service Coverage Ratio | -14.723 | ▲1.652 | ▲11.845 |
| Interest Coverage Ratio | -30.785 | ▼-4.967 | ▲5.501 |
| Short Term Operating Cash Flow Coverage Ratio | 122.201 | ▲122.201 | ▲97.761 |
| Operating Cash Flow Coverage Ratio | 0.997 | ▲0.541 | ▲0.500 |
| Capital Expenditure Coverage Ratio | 4.051 | ▼-0.492 | ▲0.582 |
| Dividend Paid And Capex Coverage Ratio | 4.051 | ▼-0.492 | ▲0.582 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -70.404 | ▼-12.878 | ▼-10.389 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $55.88B | $37.46B | $28.18B | $16.95B | $52.18B | |
| Enterprise value | $56.48B | $38.56B | $29.27B | $15.53B | $50.41B | |
| EV / Sales | 11.55x | 10.70x | 10.46x | 6.98x | 26.27x | |
| EV / Op. cash flow | 31.44x | 46.89x | 63.88x | 42.05x | 76.49x | |
| EV / Free cash flow | 41.74x | 60.12x | 236.01x | -266.06x | 90.35x | |
| EV / EBITDA | -70.40x | -57.53x | -32.13x | -20.38x | -119.64x | |
| Net debt / EBITDA | -0.74x | -1.63x | -1.19x | 1.86x | 4.20x | |
| Current ratio | 0.95x | 1.02x | 1.07x | 1.55x | 1.73x | |
| Income quality | -1.68x | -0.87x | -0.40x | -0.40x | -1.31x | |
| Graham net-net | -$8 | -$6 | -$6 | -$3 | -$1 | |
| Tax burden | 99.7% | 99.9% | 99.4% | 99.3% | 97.6% | |
| Interest burden | 103.9% | 104.4% | 103.5% | 104.3% | 101.4% | |
| Working capital | -$228.4M | $64.8M | $223.0M | $1.36B | $1.58B | |
| Invested capital | $1.47B | $1.57B | $1.78B | $2.67B | $2.25B | |
| Return on assets | -11.1% | -13.0% | -18.7% | -17.2% | -10.8% | |
| Operating ROA | -14.7% | -15.9% | -21.8% | -18.6% | -15.5% | |
| Return on tangible assets | -11.3% | -13.4% | -19.3% | -17.8% | -11.2% | |
| Return on equity | -270.0% | -422.4% | -1510.0% | -302.1% | -84.1% | |
| Return on invested capital | -26.8% | -29.2% | -39.0% | -31.1% | -20.2% | |
| Return on capital employed | -27.8% | -30.3% | -40.4% | -31.9% | -20.7% | |
| Earnings yield | -1.9% | -2.5% | -4.1% | -5.5% | -0.9% | |
| Free cash flow yield | 2.4% | 1.7% | 0.4% | -0.3% | 1.1% | |
| Capex / Op. cash flow | 24.7% | 22.0% | 72.9% | 115.8% | 15.3% | |
| Capex / Depreciation | 196.4% | 79.9% | 160.5% | 328.8% | 133.7% | |
| Capex / Sales | 9.1% | 5.0% | 11.9% | 19.2% | 5.3% | |
| SG&A / Sales | 16.9% | 16.1% | 19.2% | 18.6% | 20.3% | |
| R&D / Sales | 32.1% | 40.1% | 44.8% | 39.3% | 27.8% | |
| Stock comp / Sales | 23.1% | 28.2% | 31.0% | 26.5% | 17.8% | |
| Intangibles / Total assets | 1.7% | 2.5% | 3.2% | 3.5% | 3.9% | |
| Days sales outstanding | 70d | 64d | 68d | 62d | 58d | |
| Days payables outstanding | 22d | 20d | 34d | 47d | 47d | |
| Operating cycle | 70d | 64d | 68d | 62d | 58d | |
| Cash conversion cycle | 48d | 45d | 34d | 15d | 11d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+49.2%EV / Sales ▲+7.9%EV / EBITDA ▼-22.4%EV / Op. cash flow ▼-15.449Earnings yield ▲+0.006
Profitability
Return on equity ▲+1.524Return on assets ▲+0.019Return on invested capital ▲+0.024Return on capital employed ▲+0.025Operating ROA ▲+0.012Income quality ▼-0.802Tax burden ▼-0.002
Efficiency
Days sales outstanding ▲+5.548Days payables outstanding ▲+2.570Operating cycle ▲+5.548Cash conversion cycle ▲+2.979Capex / Sales ▲+0.040R&D / Sales ▼-0.080
Balance-sheet strength
Current ratio ▼-0.062Net debt / EBITDA ▲+0.887Working capital ▼-293189000.000Invested capital ▼-97815000.000Intangibles / Total assets ▼-0.008
Change over 5 years
Valuation
Market cap ▲+7.1%EV / Sales ▼-56.0%EV / EBITDA ▲+41.2%EV / Op. cash flow ▼-45.048Earnings yield ▼-0.010
Profitability
Return on equity ▼-1.859Return on assets ▼-0.004Return on invested capital ▼-0.066Return on capital employed ▼-0.071Operating ROA ▲+0.007Income quality ▼-0.367Tax burden ▲+0.021
Efficiency
Days sales outstanding ▲+11.394Days payables outstanding ▼-25.197Operating cycle ▲+11.394Cash conversion cycle ▲+36.591Capex / Sales ▲+0.038R&D / Sales ▲+0.043
Balance-sheet strength
Current ratio ▼-0.775Net debt / EBITDA ▼-4.947Working capital ▼-1811040000.000Invested capital ▼-784725000.000Intangibles / Total assets ▼-0.022
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-12-24 | Gilbert Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-11-07 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-10-22 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2025-10-16 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Valerie Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-06-16 | James E Hon Banks | Sale | $1,001 - $15,000 |
| 2023-01-31 | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 2023-01-20 | Nancy Pelosi | Sale (Full) | $0 - $1,000 |
| 2022-12-28 | Nancy Pelosi | Sale (Partial) | $100,001 - $250,000 |
| 2022-05-25 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-12-20 | Nancy Pelosi | Purchase | $250,001 - $500,000 |
| 2021-11-19 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-11-09 | James E Hon Banks | Sale (Full) | $1,001 - $15,000 |
| 2021-11-09 | James E Hon Banks | Sale (Full) | $15,001 - d |
| 2021-11-02 | James E Hon Banks | Purchase | $15,001 - $50,000 |
| 2021-10-26 | James E Hon Banks | Sale (Full) | $15,001 - $50,000 |
| 2021-09-30 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-09-13 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-09-09 | James E Hon Banks | Sale (Full) | $1,001 - $15,000 |
| 2021-08-30 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-08-25 | James E Hon Banks | Sale (Full) | $1,001 - $15,000 |
| 2021-08-25 | James E Hon Banks | Sale (Partial) | $1,001 - $15,000 |
| 2021-06-30 | Thomas Suozzi | Sale (Full) | $15,001 - $50,000 |
| 2021-06-25 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-06-25 | James E Hon Banks | Purchase | $1,001 - $15,000 |
| 2021-06-25 | James E Hon Banks | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-25 Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar Law Office is Investigating Claims on Your Behalf PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). What is The Investigation About?
- 2026-08-21 Wonder Works Studio Reveals The Creator Advantage On Roblox In late 2024, Zach Letter says Wonder Works Studio was running out of cash.
- 2026-08-19 Australia secures court-enforceable child safety undertaking from Roblox Australia''s internet regulator secured a court-enforceable undertaking from Roblox to improve protections against grooming and sexual exploitation, after tests found adult strangers could still contact children despite safety measures introduced by the world''s biggest gaming platform.
- 2026-08-12 Airbnb vs. Roblox: Which Stock Is a Better Buy in 2026? Airbnb operates a massive travel marketplace with millions of active listings and strong free cash flow generation. Roblox commands a rapidly growing user base of millions who create and consume digital experiences in a virtual ecosystem.
- 2026-08-07 Bronstein, Gewirtz & Grossman LLC Urges Roblox Corporation Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - August 7, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
- 2026-08-07 RBLX UPCOMING DEADLINE : The Gross Law Firm Alerts Roblox Corporation Stockholders of Securities Class Action - Contact the Firm NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Roblox Corporation (NYSE: RBLX).
- 2026-08-07 RBLX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Notifies Roblox (RBLX) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026 NEW YORK--(BUSINESS WIRE)---- $RBLX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) and reminds investors of the August 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.
- 2026-08-07 Bank of America Corp DE Decreases Stock Holdings in Roblox Corporation $RBLX Bank of America Corp DE trimmed its position in Roblox Corporation (NYSE: RBLX) by 28.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,353,704 shares of the company''s stock after selling 952,539 shares during the period. Bank of
- 2026-08-06 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Roblox Corporation of Class Action Lawsuit and Upcoming Deadlines - RBLX NEW YORK , Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Roblox Corporation ("Roblox" or the "Company") (NYSE: RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 2026-08-06 A Roblox Director Sells 16,666 Shares Amid a Sinking Stock Price. Here''s What That Means to Investors. The disposal of 16,666 shares was executed at a weighted average price of $37.46 per share, totaling approximately $624,308. The transaction reduced the reporting owner''s total direct and indirect equity position by 0.14%.